Tidal Investments LLC increased its stake in Tapestry, Inc. (NYSE:TPR) by 14.7% in the second quarter, bringing its total holdings to 67,741 shares valued at approximately $9.9 million. This luxury accessories retailer has seen significant institutional interest, with 90.77% of its stock owned by institutional investors. Tapestry also reported strong financial results, beating earnings and revenue expectations, raising its quarterly dividend, and maintaining a "Moderate Buy" consensus rating from analysts, despite some insider share sales.

The Manufacturers Life Insurance Company has reduced its stake in Parker-Hannifin Corporation (NYSE:PH) by selling 4,025 shares, retaining 83,214 shares valued at $81.4 million. This comes as Parker-Hannifin reported strong quarterly results, beating EPS estimates and seeing a 9.8% year-over-year revenue increase, with favorable analyst ratings and an average price target of $1,114.55. The company also maintains a quarterly dividend of $2.00 per share.

Tidal Investments LLC significantly increased its stake in 3M Company, acquiring an additional 8,865 shares to hold a total of 72,314 shares valued at $11.7 million. This move is part of broader institutional investor activity, with hedge funds and other institutional investors collectively owning 65.25% of 3M's stock. The company recently reported strong Q2 earnings, surpassing expectations with $2.40 EPS and $6.50 billion in revenue, and pays a quarterly dividend of $0.78, reflecting a 1.9% yield.

The Manufacturers Life Insurance Company reduced its stake in 3M Company by 5.8% in the second quarter of 2026, selling 17,419 shares. This comes despite many other institutional investors, such as California State Teachers Retirement System and Amundi, significantly increasing their holdings. 3M reported strong quarterly earnings, beating EPS estimates, and analysts currently hold a consensus "Hold" rating with an average price target of $177.21.

Virginia Retirement Systems initiated a new $1.84 million position in lululemon athletica inc. by purchasing 16,150 shares. This investment comes amidst weakening fundamentals for Lululemon, including a 4.3% year-over-year revenue decline and a reduced FY2026 revenue outlook. Despite a cautious analyst sentiment and an average "Reduce" rating, the stock's low valuation is attracting some contrarian investors like Michael Burry.

Senator Cory A. Booker recently sold shares of McDonald's Corporation (NYSE:MCD), along with holdings in Netflix, NVIDIA, Alnylam Pharmaceuticals, JD.com, and Amazon. The McDonald's sale, valued between $15,001 and $50,000, occurred on August 11th. Despite beating EPS estimates and reporting revenue growth, McDonald's stock opened near its 12-month low, though analysts maintain a "Moderate Buy" consensus with an average price target of $320.57.

The Manufacturers Life Insurance Company reduced its stake in Gilead Sciences (NASDAQ:GILD) by 11.9% in the second quarter, selling 148,344 shares but still holding over 1 million shares valued at $138.2 million. Gilead Sciences reported strong quarterly results with $7.8 billion in revenue and an adjusted EPS of negative $6.75, both exceeding analyst expectations. The company also declared a quarterly dividend of $0.82 per share, while analysts maintain a "Moderate Buy" rating with an average price target of $158.78.

Sequoia Financial Advisors LLC has increased its stake in Gilead Sciences, Inc. by 16.9% in the second quarter, bringing its total holdings to 58,662 shares valued at $7.4 million. This move is part of broader institutional interest, with hedge funds and institutional investors collectively owning 83.67% of Gilead's stock. Despite some insider selling, analysts generally maintain a "Moderate Buy" rating for GILD, with an average price target of $158.78.

The Manufacturers Life Insurance Company increased its stake in CVS Health Corporation by 5.8% in Q2, acquiring an additional 70,197 shares to hold a total of 1.29 million shares valued at $133.2 million. Analysts maintain a "Moderate Buy" rating for CVS with a consensus price target of $107.24. CVS recently reported strong Q2 earnings, with EPS of $2.58 and revenue up 7.3% year-over-year to $106.1 billion, and it continues to pay a quarterly dividend of $0.665 per share.

WINTON GROUP Ltd has acquired a new stake of 4,409 shares in Axon Enterprise, Inc (NASDAQ:AXON), valued at approximately $2.47 million. This comes as institutional investors now own 79.08% of the company, despite recent insider sales totaling $37.7 million. Analysts maintain a "Moderate Buy" rating for Axon, with an average price target of $721.57, following strong quarterly revenue growth and exceeding EPS estimates.